Allen Institute's board of directors
The Board of Directors is charged with providing oversight and stewardship to the Allen Institute helping to ensure it fulfills its scientific mission.
As Chair of Vulcan and Trustee of the Paul G. Allen Trust, Jody Allen has responsibility for preserving and implementing Paul Allen’s vision for generations to come.
Jody and her brother Paul Allen worked side-by-side in both business and philanthropic ventures. For more than two decades, Jody served as CEO of Vulcan, which she co-founded with Paul. She also co-founded and currently serves on the board of The Paul G. Allen Family Foundation. In addition, Jody is the President of the Board of MoPOP – Seattle’s critically acclaimed museum of popular culture – and the Chair of the Allen Institute’s Board of Directors.
As a philanthropist with a passion for conservation, she has dedicated herself to protecting marine life, fighting wildlife trafficking, and saving Africa’s elephants from extinction. She launched Wild Lives Foundation, a nonprofit organization dedicated to wildlife conservation and other philanthropic initiatives. In addition, Jody serves as a board member of Sealife Response, Rehabilitation and Research, an organization dedicated to improving the health and welfare of marine wildlife in the Pacific Northwest.
Jody has a deep love for education and the arts. She is currently a board member of the Zeitz Museum of Contemporary Art Africa, and previously served on the boards of ArtsFund, the Theatre Communications Group, the University of Washington Foundation, the Museum of Glass, the Los Angeles International Film Festival and the Oregon Shakespeare Festival.
Jody is a member of the board of the Seattle Seahawks. Recognizing the team’s role as a powerful catalyst for civic pride as well as an economic engine, she led the development of CenturyLink Field and Event Center. Jody also led the development of Moda Center, home of the Portland Trail Blazers.
Deloitte Consulting LLP
Margaret is a Managing Director with Deloitte Consulting LLS where she is focused on bringing forward her experience with trends in biomedical research innovation and patient engagement to help strengthen nonprofit organizations, as well as federal health and commercial life sciences programs. She joined Deloitte from FasterCures, a center of the Milken Institute where she was Executive Director. While at FasterCures, she oversaw programs advancing the science of patient input, examining the metrics for collaborative research models, and policy related to federal research. She has also worked on public health issues at the American Public Health Association and in a consulting and policy capacity for HIV/AIDS programs in the early years of the epidemic. She began her career at the Congressional Office of Technology Assessment looking at the impact of biotechnology and genetics on the economy and society.
Margaret currently serves on the Boards of Act for NIH, FasterCures, Friends of Cancer Research, and the Melanoma Research Alliance. Margaret has a Bachelor’s from University of Maryland in Government and Politics and a Master’s from George Washington in Science, Technology and Public Policy.
Nathaniel T. "Buster" Brown
Rain City Capital, LLC
Buster Brown is the Executive Vice President Chief Financial Officer for Rain City Capital, LLC. Rain City Capital provides bridge financing solutions to real estate investors and professionals.
Buster has been the Chief Financial Officer for an eclectic industry mix. He was the Senior Vice President of Finance for the Seattle Times Company and has served as Chief Financial Officer for several Paul G. Allen companies, including Vulcan, Mr. Allen’s multi-billion-dollar asset management company; the Seattle Seahawks; and First and Goal, the company that built and manages CenturyLink Field.
Buster serves two for-profit boards (GemaTEG and Fortune Management Inc) and several nonprofit boards including the Allen Institute, MoPOP and the Seattle Seahawks Charitable Foundation. Buster is a member of the Washington Society of Certified Public Accountants as well as the American Institute of Certified Public Accountants.
Buster is a CPA and earned a B.A. in Business Administration and an MBA from the University of Puget Sound.
Phyllis J. Campbell
JPMorgan Chase & Co
Phyllis Campbell is Chairman of the Pacific Northwest Region for JPMorgan Chase. She is the firm’s senior executive in Washington, Oregon and Idaho. From 2003 to 2009, Ms. Campbell served as president and CEO of The Seattle Foundation, one of the nation’s largest community philanthropic foundations. She was president of U.S. Bank of Washington from 1993 until 2001 and served as chair of the bank’s Community Board.
She has received several awards for her corporate and community involvement, including Women Who Make A Difference and Director of the Year from the Northwest Chapter of the National Association of Corporate Directors.
Ms. Campbell currently serves on the boards of Alaska Air Group and Toyota's Diversity Advisory Board. She is also the chair of the US-Japan Council, as well as a member of the global advisory board of Women Corporate Directors (WCD).
She holds a bachelor’s degree from Washington State University and an MBA from the University of Washington.
University of Wisconsin
Alta Charo (B.A. biology, Harvard 1979; J.D. Columbia, 1982) is the Warren P. Knowles Professor Emerita of Law & Bioethics at the University of Wisconsin. Prior to her 1989 arrival at UW, Charo served as Associate Director of the Legislative Drafting Research Fund of Columbia University; Fulbright Lecturer in American Law at the Sorbonne in Paris; legal analyst at the congressional Office of Technology Assessment; and AAAS Diplomacy Fellow at USAID. Professor Charo took leave from UW for 2009-2011 to serve as a senior policy advisor on emerging technology issues in the FDA Office of the Commissioner. Other government service includes membership on President Clinton’s National Bioethics Advisory Commission (1996-2001).
At present, Charo is serving as the inaugural David A. Hamburg Distinguished Fellow at the Nuclear Threat Initiative, where she is focused primarily on the Biosecurity Innovation and Risk Reduction Initiative. She is also the lead co-chair of the 4S (safety, security, sustainability and social responsibility) team for BioMADE, a DoD-led Manufacturing USA Institute with a vision to build a sustainable, domestic end-to-end bioindustrial manufacturing ecosystem.
Charo has been elected to the National Academy of Medicine (“NAM,” formerly known as the IOM), as well as the American Association for the Advancement of Science (AAAS) and the American Academy of Arts & Sciences. At the National Academies, Professor Charo was a member of the IOM/NAM Council, various NAS and NAM boards on health and science policy, and multiple committees focused on topics ranging from bioterrorism to infectious disease risks to long-term space travel health concerns. In the past she co-chaired the NAS/NAM committee to develop national voluntary guidelines for stem cell research and its committee charged with making recommendations on the use of gene-editing for both somatic and germline (heritable) changes in humans. Currently she is a member of the World Health Organization's expert advisory committee on global governance of genome editing, and co-chair of the National Academies’ committee on principles for governance for emerging technologies.
Thomas L. Daniel, Ph.D.
University of Washington
Tom is a Professor in the Department of Biology at the University of Washington with adjunct appointments in Bioengineering, Computer Science & Engineering, and Mechanical Engineering. His research and teaching melds neuroscience, computing, and biomechanics to understand the control and dynamics of movement in biology. He was MacArthur Fellow, a Guggenheim Fellow and a Fellow of the American Association for Advancement of Science. He is on the board of reviewing editors for Science Magazine, the Board of Directors for Allen Institute, the Biological Sciences Advisory Committee for the NSF, and is the US representative for the Council of Scientists for the Human Frontiers of Science Program.
Carla DewBerry is a Partner at K&L Gates, where she practices in the areas of health care law; mergers and acquisitions; and federal, state and local tax. Ms. DewBerry represents health care clients in Medicare and Medicaid reimbursement matters, including related audits and litigation. In addition, she is an experienced tax and business counselor and represents clients in corporate restructurings, joint venture operations, licensing, and federal and state taxation matters. She provides counsel for clients outside the health care industry as well.
Ms. DewBerry's experience includes working as a practicing CPA at a large accounting firm where she was part of a firmwide health care group. She brings to her law practice a practical, in-depth understanding of how financial information is generated, stored and retrieved in the health care industry. This understanding is especially helpful in Medicare/Medicaid reimbursement matters.
Most recently, Ms. DewBerry was an owner of the private law practice Garvey Schubert Barer. The primary areas of focus included general corporate law, tax law, and health care law with an emphasis in regulatory compliance (federal and local) and reimbursement issues. Previous to that, she was a shareholder in Bennett Bigelow & Leedom, P.S., a law firm specializing in health care services. Ms. DewBerry was also a tax manager of a large multi-national accounting firm where her primary areas of focus included hospital reorganizations, federal and state tax law, and health care reimbursement.
Ms. DewBerry earned a B.S. from University of San Francisco and a J.D. from UC Berkeley School of Law.
Steve Hall has been a venture capital investor for over 20 years, including his current tenure at Vulcan Capital where he managed investments in over 50 companies totaling more than $1.0B in combined value. He currently sits on the boards of Zola Electric and High Fidelity and has been a board member for both the Allen Institute and the Allen Institute for Artificial Intelligence since inception.
Steve began his career as a corporate attorney with White & Case in New York, where he focused on M&A and securities transactions. Steve graduated from Furman University and received his JD from Columbia University Law School, where he was a Harlan Fiske Stone Scholar.
Allan Jones, Ph.D.
Allan Jones is President-Emeritus and founding CEO of the Allen Institute. Jones was one of the Allen Institute’s first four employees when the nonprofit launched in 2003, originally as the Allen Institute for Brain Science, and took the helm within the first few years to manage its growth and impact, eventually leading the launch of the Institute’s other four scientific divisions. Along with the Allen Institute’s founder, the late philanthropist Paul G. Allen, Jones pioneered a unique approach to neuroscience, and later to other areas of bioscience, through the Institute’s core principles of big science, team science and open science. Jones has continued to champion the need for open data sharing and the broader importance of open science. After 18 years with the organization, Jones stepped down as President and CEO in January 2022.
Jones’ publications have garnered approximately 1,000 highly influential citations on Semantic Scholar. His 2011 TED Talk: “A map of the brain” has been viewed nearly 1.25 million times. He has advised and helped organize many current U.S. and global neuroscience initiatives, including the National Institutes of Health’s BRAIN Initiative, the Human Brain Project and the International Brain Initiative. Jones currently serves on several advisory boards and the Fred Hutchinson Cancer Research Center Board of Trustees, and he is the former Chair of the World Economic Forum’s Global Agenda Council on Neuroscience and Behavior.
Originally from Wichita, Kansas, Jones received a B.S. in biology from Duke University and a Ph.D. in genetics and developmental biology from Washington University School of Medicine. After a brief period as a post doc at the University of Pennsylvania, Jones joined Avitech Diagnostics, a small start-up company in Philadelphia. He moved to Seattle to work for Rosetta Inpharmatics, which was later acquired by Merck and Co.
Allen D. Israel, MBA, JD
Foster Garvey PC
Allen Israel has practiced law for over forty years at the firm of Foster Garvey PC (formerly Foster Pepper PLLC) in Seattle, where his practice has included a variety of investment, technology, sports teams, sports facilities, real estate, and other businesses; non-profits such as museums and foundations; and a diversified personal holding and management company. Allen has served on the Board of the Allen Institute since 2004.
Interim President of Bellevue College
Gary Locke previously served as the 21st Governor of Washington State and was U.S. Secretary of Commerce and then U.S. Ambassador to China under the Obama Administration. He also served as a senior advisor and consultant to the law firm of Davis Wright Tremaine with an emphasis on trade, regulatory, and investment policy issues and providing guidance on doing business in China.
Governor Locke currently serves as the Interim President at Bellevue College, which is the third largest higher education institution in Washington State, serving nearly 30,000 students annually.
Governor Locke currently serves on the boards of AMC Theaters, nLight, Port Blakely Tree Farm, and the Seattle Art Museum and is a past board member of PATH and Fortinet. He holds a bachelor’s degree in political science from Yale University and a law degree from Boston University.
Michael P. Stryker, Ph.D.
University of California, San Francisco
Michael Stryker is William Francis Ganong Professor in the Department of Physiology at the University of California, San Francisco, where he has been a faculty member since his appointment as Assistant Professor in 1978 and where he served as Department Chair from 1994-2005. In 1987-1988 he was Visiting Professor in the Department of Human Anatomy at the University of Oxford in England. Dr. Stryker earned his B.A. in Philosophy with a minor in Mathematics from the University of Michigan, Ann Arbor and his Ph.D. degree in Psychology and Brain Sciences (Neurophysiology) from the Massachusetts Institute of Technology. From 1976-1978 he was Research Fellow in Neurobiology at Harvard Medical School, where he worked with Nobel Laureates Torsten Wiesel and David Hubel. Dr. Stryker has received several awards and honors for his research, including election to membership in the National Academy of Sciences and the American Academy of Arts and Sciences, appointment as the Galileo Galilei Professor of Science at Scuola Normale Superiore in Pisa, Italy (1993), the Pepose Vision Sciences Award from Brandeis University, and the Stein Innovator Award from Research to Prevent Blindness.